Skip to main content

Activated CaMKII Binds to the mGlu Metabotropic Glutamate Receptor and Modulates Calcium Mobilization.

Citation
Marks, C. R., et al. “Activated Camkii Binds To The Mglu Metabotropic Glutamate Receptor And Modulates Calcium Mobilization.”. Molecular Pharmacology, pp. 1352-1362.
Center Vanderbilt University
Author Christian R Marks, Brian C Shonesy, Xiaohan Wang, Jason R Stephenson, Colleen M Niswender, Roger J Colbran
Abstract

Ca/calmodulin-dependent protein kinase II (CaMKII) and metabotropic glutamate receptor 5 (mGlu) are critical signaling molecules in synaptic plasticity and learning/memory. Here, we demonstrate that mGlu is present in CaMKII complexes isolated from mouse forebrain. Further in vitro characterization showed that the membrane-proximal region of the C-terminal domain (CTD) of mGlu directly interacts with purified Thr286-autophosphorylated (activated) CaMKII However, the binding of CaMKII to this CTD fragment is reduced by the addition of excess Ca/calmodulin or by additional CaMKII autophosphorylation at non-Thr286 sites. Furthermore, in vitro binding of CaMKII is dependent on a tribasic residue motif Lys-Arg-Arg (KRR) at residues 866-868 of the mGlu-CTD, and mutation of this motif decreases the coimmunoprecipitation of CaMKII with full-length mGlu expressed in heterologous cells by about 50%. The KRR motif is required for two novel functional effects of coexpressing constitutively active CaMKII with mGlu in heterologous cells. First, cell-surface biotinylation studies showed that CaMKII increases the surface expression of mGlu Second, using Ca fluorimetry and single-cell Ca imaging, we found that CaMKII reduces the initial peak of mGlu-mediated Ca mobilization by about 25% while doubling the relative duration of the Ca signal. These findings provide new insights into the physical and functional coupling of these key regulators of postsynaptic signaling.

Year of Publication
2018
Journal
Molecular pharmacology
Volume
94
Issue
6
Number of Pages
1352-1362
Date Published
12/2018
ISSN Number
1521-0111
DOI
10.1124/mol.118.113142
Alternate Journal
Mol. Pharmacol.
PMID
30282777
PMCID
PMC6207916
Download citation